Why Relief Veterinary Jobs Are the Hottest Thing in Vet Med Right Now
If you've been scrolling through veterinary job listings lately, you've probably noticed something: relief vet jobs are everywhere. And according to Dr. Ashley Hopkins, founder of Hopper Vets and one of veterinary medicine's most passionate advocates for career flexibility, there's a very good reason for that.
The Half-Trillion Dollar Question: Where Does Veterinary Medicine Fit in Pet Care's Explosive Growth?
As the global pet care market prepares to double over the next decade, veterinary professionals are discovering they're no longer just healthcare providers. They're wellness consultants, nutrition experts, and technology interpreters in an industry that's fundamentally reimagining what it means to care for animals.
Vet Candy’s Free NAVLE Course Could Change How Vet Students Study Forever
Vet Candy today announced major updates to its free NAVLE Prep Intensive Program, expanding the platform with new specialist-led video content, an original six-book educational series, a practice question bank, and enhanced multimedia learning tools designed to support veterinary students preparing for licensure.
AKC Humane Fund Expands Mission to Support Pet Owners with Critical Veterinary Care
The AKC Humane Fund is expanding its mission — and this time, it’s targeting one of the biggest pain points in veterinary medicine: access to critical care.
ASPCA Offering New Scholarship for Veterinary Students
The American Society for the Prevention of Cruelty to Animals has launched a new scholarship initiative aimed at reducing financial barriers for veterinary and veterinary technician students pursuing careers in animal welfare and community-based medicine.
FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs
The United States Food and Drug Administration has approved NUMELVI™ (atinvicitinib tablets), a new treatment for itch associated with allergic dermatitis in dogs, developed by Merck Animal Health. The company says the medication is the first and only second-generation Janus kinase (JAK) inhibitor approved in the United States for this indication.